Drug profile · INN
eteplirsen
EXONDYS
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
eteplirsen (EXONDYS) is an FDA-listed pharmaceutical active ingredient. Associated with Sarepta Therapeutics. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN eteplirsen
Brand EXONDYS
Route INTRAVENOUS
Formulation SOLUTION
ATC code M09AX
Originator Sarepta Therapeutics
Frequently asked questions
What is eteplirsen?
eteplirsen (EXONDYS) is an FDA-listed pharmaceutical active ingredient. Associated with Sarepta Therapeutics. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for eteplirsen?
EXONDYS is a marketed brand name for eteplirsen. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of eteplirsen?
eteplirsen has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.